SUMMARY
- Skoka raised $21.5 million in funding.
- The funds will support manufacturing and expansion.
- Skoka makes nicotine pouches for adults.
Follow us
Follow usSkoka, an Austin, TX-based nicotine pouch company built for adult nicotine consumers, has raised $21.5 million in a funding round.
The round saw backers including Darren Throop, Mark Hastings, Anthony Kim, Sam Gagner, Beau Allen, Jack Eichel, Dylan Larkin, Scottie Upshall, and others.
The company plans to use the funding for regulatory preparation, manufacturing expansion, team growth and future commercialisation. Its products remain subject to review and marketing authorisation by the US Food and Drug Administration (FDA).
What is Skoka?
Skoka develops nicotine pouches for adult nicotine consumers. The company focuses on proprietary formulations, flavour systems, and ingredient transparency.
Read More:Casap Raises $56M in Series B Funding Led by Base10 Partners
Its products use nine exclusive ingredients, including plant-based sweeteners and plant-derived ingredients. Skoka has also filed two patent applications covering its ingredients and how they are blended.
The company plans to publish its full ingredient list on its website at launch. Its products are manufactured in the United States at FDA-registered facilities using globally sourced ingredients.
RECOMMENDED FOR YOU
How Much Funding Has Skoka Raised?
Skoka has raised $21.5 million in its latest funding round. The company has not disclosed details of previous funding rounds or its total funding raised to date.
Who Invested in Skoka’s Funding Round?
The round attracted investors from sports, business, and consumer industries.
Named investors include Darren Throop, Mark Hastings, Anthony Kim, Sam Gagner, Beau Allen, Jack Eichel, Dylan Larkin, and Scottie Upshall, among others.
The company said its investor group includes more than a dozen professional athletes from hockey, football, and golf, along with hockey team owners, corporate investors, and executives from beverage and dietary supplement businesses.
Why the Funding Matters
Skoka will use the capital to prepare for regulatory requirements, increase manufacturing capacity, and expand its team.
The company has committed $15 million to its Premarket Tobacco Product Application (PMTA) programme. It submitted its bundled PMTA to the FDA on October 1. Its regulatory package includes three completed pharmacokinetic studies and research covering product stability, toxicology, actual use, and label comprehension.
Skoka's regulatory team has previously supported more than 200 products through the PMTA process. However, the company's products still require FDA review and marketing authorisation.
Who founded Skoka?
Skoka was founded by Dan Aziz. The company is based in Austin, Texas.
Aziz's experience with nicotine pouches and conversations with friends in professional sports helped inspire the business. He wanted to develop products with clearly defined ingredients and named the company after Lake Muskoka in Ontario, Canada.
“We had the opportunity to go to retail last year. We turned it down,” Aziz said. “We built this company science first. We developed a differentiated base formula using ingredients not traditionally found in nicotine pouches, and then we invested in a comprehensive bundled PMTA before going to market.
“I have been a long-time nicotine and tobacco user and tried most pouches in the market, after my first time being introduced to Skoka, I knew I wanted to be a part of it,” said Anthony Kim.
Market and Business Growth
Skoka introduced its brand to retailers, distributors, and buyers at the NACS Show in Las Vegas in October 2026.
The company is also the exclusive nicotine pouch partner of Authentic Live. Its products are made in the United States, and it has filed two patent applications covering its formulations and ingredient combinations.
What Happens Next?
Skoka plans to continue its regulatory preparation, scale manufacturing, and grow its team. Its next steps also include preparing for future commercialisation, subject to FDA review and marketing authorisation.
Read More:Opentrons Labworks Secures $40M in Series E Funding
Recommended Stories for You
Devin Jacobs Jan 24, 2024
Devin Jacobs Mar 30, 2026
Devin Jacobs Mar 13, 2024
Devin Jacobs Aug 22, 2026
Devin Jacobs Jan 26, 2024
Devin Jacobs May 9, 2024
Trending Stories
Goodfire Raises $50M Series A to Advance AI Interpretability and Launch Ember Platform
Observe Closes $156M in Series C Funding
Dental Care Wally Health Secures $25M in Series A Funding
Metcash Announces Expanded Strategic Partnership with Coveo
Siena Raises $17M in Series A Funding Led by York IE
Illinois-Based CDW Completes Acquisition of AI Services Company Lovelytics
Create Wellness Raises $20M in Series B Funding
[Funding alert] CA-based rabbit Secures Additional $10M in Series A Round Funding
